ConductScience.org, home

Paper32152607

An open-source drug discovery platform enables ultra-large virtual screens.

Gorgulla C and 14 others. Nature, 2020. Cited by 453 papers, by iCite.

Cite this record

ConductScience Library. An open-source drug discovery platform enables ultra-large virtual screens. Papers, record 32152607. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32152607

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
An open-source drug discovery platform enables ultra-large virtual screens.
PubMed
Journal
Nature
PubMed
Year
2020
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
453
iCite
Relative citation ratio, by iCite
22.6
iCite
Revised in PubMed
2026-07-26
PubMed

Authors15

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gorgulla CChristophhttps://orcid.org/0000-0001-6986-5270
2Boeszoermenyi AAndrashttps://orcid.org/0000-0001-9810-7241
3Wang ZFZi-Fu
4Fischer PDPatrick Dhttps://orcid.org/0000-0003-4160-5295
5Coote PWPaul W
6Padmanabha Das KMKrishna Mhttps://orcid.org/0000-0002-0116-4256
7Malets YSYehor Shttps://orcid.org/0000-0002-3029-3065
8Radchenko DSDmytro Shttps://orcid.org/0000-0001-5444-7754
9Moroz YSYurii Shttps://orcid.org/0000-0001-6073-002X
10Scott DADavid Ahttps://orcid.org/0000-0003-3243-528X
11Fackeldey KKonstantinhttps://orcid.org/0000-0002-4373-3672
12Hoffmann MMoritzhttps://orcid.org/0000-0002-9533-8586
13Iavniuk IIrynahttps://orcid.org/0000-0002-9006-4010
14Wagner GGerhard
15Arthanari HHaribabuhttps://orcid.org/0000-0002-7281-1289

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Drug DiscoveryMajor topic
Drug Evaluation, PreclinicalMajor topic
Molecular Docking SimulationMajor topic
SoftwareMajor topic
User-Computer InterfaceMajor topic
Access to Information
Automation
Cloud Computing
Computer Simulation
Databases, Chemical
Kelch-Like ECH-Associated Protein 1
Ligands
Molecular Targeted Therapy
NF-E2-Related Factor 2
Reproducibility of Results
Thermodynamics

Source PubMed

Download CSV of topics

Grants8

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 AI150709NIAID NIH HHSUnited StatesR01AI150709PubMedNIH RePORTER
R01 GM129026NIGMS NIH HHSUnited StatesR01GM129026PubMedNIH RePORTER
R01 AI037581NIAID NIH HHSUnited StatesR01AI037581PubMed and NIHNIH RePORTER
CA200913NIH HHSUnited StatesPubMedPubMed
GM129026NIH HHSUnited StatesPubMedPubMed
R01 CA200913NCI NIH HHSUnited StatesR01CA200913PubMedNIH RePORTER
J 3872Austrian Science Fund FWFAustriaPubMedPubMed
AI037581NIH HHSUnited StatesR01AI037581PubMed and NIHNIH RePORTER

Download CSV of grants

References33

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126928437Innovation in the pharmaceutical industry: New estimates of R&D costs.J Health Econ2016https://conductscience.org/library/papers/26928437PubMed
230728502Ultra-large library docking for discovering new chemotypes.Nature2019https://conductscience.org/library/papers/30728502PubMed
318304355DOVIS: an implementation for high-throughput virtual screening using AutoDock.BMC Bioinformatics2008https://conductscience.org/library/papers/18304355PubMed
418778471DOVIS 2.0: an efficient and easy to use parallel virtual screening tool based on AutoDock 4.0.Chem Cent J2008https://conductscience.org/library/papers/18778471PubMed
529133831Protein-Ligand Blind Docking Using QuickVina-W With Inter-Process Spatio-Temporal Integration.Sci Rep2017https://conductscience.org/library/papers/29133831PubMed
68788213The art and practice of structure-based drug design: a molecular modeling perspective.Med Res Rev1996https://conductscience.org/library/papers/8788213PubMed
728790194Characterization of the Potent, Selective Nrf2 Activator, 3-(Pyridin-3-Ylsulfonyl)-5-(Trifluoromethyl)-2H-Chromen-2-One, in Cellular and In Vivo Models of Pulmonary Oxidative Stress.J Pharmacol Exp Ther2017https://conductscience.org/library/papers/28790194PubMed
829750408Non-covalent Small-Molecule Kelch-like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Inhibitors and Their Potential for Targeting Central Nervous System Diseases.J Med Chem2018https://conductscience.org/library/papers/29750408PubMed
927031670
Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery.
J Med Chem2016https://conductscience.org/library/papers/27031670PubMed
1030610225Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases.Nat Rev Drug Discov2019https://conductscience.org/library/papers/30610225PubMed
1126479676ZINC 15--Ligand Discovery for Everyone.J Chem Inf Model2015https://conductscience.org/library/papers/26479676PubMed
1219499576AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading.J Comput Chem2010https://conductscience.org/library/papers/19499576PubMed
1325717194Fast, accurate, and reliable molecular docking with QuickVina 2.Bioinformatics2015https://conductscience.org/library/papers/25717194PubMed
1423379370Lessons learned in empirical scoring with smina from the CSAR 2011 benchmarking exercise.J Chem Inf Model2013https://conductscience.org/library/papers/23379370PubMed
1526629955AutoDockFR: Advances in Protein-Ligand Docking with Explicitly Specified Binding Site Flexibility.PLoS Comput Biol2015https://conductscience.org/library/papers/26629955PubMed
1627195023AutoDock VinaXB: implementation of XBSF, new empirical halogen bond scoring function, into AutoDock Vina.J Cheminform2016https://conductscience.org/library/papers/27195023PubMed
1726744922Vina-Carb: Improving Glycosidic Angles during Carbohydrate Docking.J Chem Theory Comput2016https://conductscience.org/library/papers/26744922PubMed
1829606412Ensemble Docking in Drug Discovery.Biophys J2018https://conductscience.org/library/papers/29606412PubMed
1923351099Consensus docking: improving the reliability of docking in a virtual screening context.J Chem Inf Model2013https://conductscience.org/library/papers/23351099PubMed
2023647822Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanism.Bioorg Med Chem2013https://conductscience.org/library/papers/23647822PubMed

See all 33 referencesDownload CSV of references

Cited by288

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 453 citations.

PMIDTitleJournalYearIn PapersSource
42943275Drugging the Undruggable in Oncology: Structural Computation, Machine Learning, and Generative AI for Historically Intractable Targets.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42943275PubMed
42894001Structure based discovery of antipsychotic-like TAAR1 agonists.Nat Commun2026https://conductscience.org/library/papers/42894001PubMed
42870399Representation-aware conformal prediction for reliable uncertainty quantification in drug-target affinity.Bioinformatics2026https://conductscience.org/library/papers/42870399PubMed
42862171Large-scale prospective evaluation of co-folding across hundreds of Mac1-ligand complexes and three virtual screens.Elife2026https://conductscience.org/library/papers/42862171PubMed
42741636Molecular Striptease of a Thiadiazolopyrimidine Hit Yields a Streamlined, Artifact-Free NADPH Mimic for NOX Inhibition.ACS Med Chem Lett2026https://conductscience.org/library/papers/42741636PubMed
42706738SMILES2Docking: An Open-Source Desktop Workflow for Ligand Ionization, Stereochemistry-Aware Preparation and Semi-Empirical 3D Refinement.Mol Inform2026https://conductscience.org/library/papers/42706738PubMed
42686980
Artificial intelligence and ultra-high performance computing methods and experiments for drug discovery: virtual screening, deep learning, molecular dynamics simulations, ADMET modelling, and experimental validation.
Mol Biomed2026https://conductscience.org/library/papers/42686980PubMed
42686903Structure and operating principles of a monkeypox virus replisome.Nature2026https://conductscience.org/library/papers/42686903PubMed
42686876Pushing the boundaries of virtual screening scale of combinatorial spaces with the V-SYNTHES approach.NPJ Drug Discov2026https://conductscience.org/library/papers/42686876PubMed
42680826AI-enhanced adaptive virtual screening of large libraries for ligand discovery.Nat Biotechnol2026https://conductscience.org/library/papers/42680826PubMed
42666875Chemical Distance-Based Acceleration of Large Library Docking with ChemSTEP.ACS Cent Sci2026https://conductscience.org/library/papers/42666875PubMed
42640361AI-driven drug design: a comprehensive review.J Comput Aided Mol Des2026https://conductscience.org/library/papers/42640361PubMed
42629474Siteomix: a PyMOL plugin for the detection, alignment, and similarity analysis of protein‒ligand binding sites.J Comput Aided Mol Des2026https://conductscience.org/library/papers/42629474PubMed
42629463
Computational identification of potential VEGFR2 inhibitors using integrated pharmacophore modeling, QSAR analysis, molecular docking, dynamics simulation, and virtual screening followed by in vitro bioassays.
J Comput Aided Mol Des2026https://conductscience.org/library/papers/42629463PubMed
42601409New paradigm of q-CAR drug development targeting disease-specific protein conformations.NPJ Drug Discov2026https://conductscience.org/library/papers/42601409PubMed
42599595Targeting WEE1 kinase: an integrated machine learning-cheminformatics framework for ultra-large-scale virtual screening and novel inhibitor discovery.J Comput Aided Mol Des2026https://conductscience.org/library/papers/42599595PubMed
42589321SurroDock: A Deep Learning Surrogate for Accelerated Pre-Docking Ligand Prioritization in Structure-Based Virtual Screening.Int J Mol Sci2026https://conductscience.org/library/papers/42589321PubMed
42584520Multimodal deep learning with a joint uncertainty quantification scheme for drug-target interaction prediction.Mol Divers2026https://conductscience.org/library/papers/42584520PubMed
42540267The Potential of AI-Driven High-Content Imaging in Drug Discovery.ACS Omega2026https://conductscience.org/library/papers/42540267PubMed
42481749Rapid and energy-efficient ultra-large library screening for drug discovery on a SpiNNaker2 neuromorphic chip.Commun Chem2026https://conductscience.org/library/papers/42481749PubMed

See all 288 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
KEAP19817PubTator's text mininghttps://conductscience.org/library/genes/9817NCBI Gene
NFE2L24780PubTator's text mininghttps://conductscience.org/library/genes/4780NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32152607

GET https://conductscience.org/api/papers/v1/32152607/references?page=2